Prashant V Bommi

6PUBLICATIONS

61CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|May 26, 2026

Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205.

|Feb 13, 2025

Rational Design and Optimization of a Potent IDO1 Proteolysis Targeting Chimera (PROTAC).

Paige J Monsen, Prashant V Bommi, Arabela A Grigorescu

|Sep 19, 2023

Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence.

Margaret Johnson, April Bell, Kristen L Lauing

|Jul 16, 2021

Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis.

Charles M Bowen, Lewins Walter, Ester Borras

|May 18, 2021

The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells.

Prashant V Bommi, Charles M Bowen, Laura Reyes-Uribe

|Nov 20, 2019

NER-factor DDB2 regulates HIF1α and hypoxia-response genes in HNSCC.

Prashant V Bommi, Vaibhav Chand, Nishit K Mukhopadhyay

Pageof 1

Frequent Collaborators

Manon Penco-Campillo

Derek A Wainwright

Craig Horbinski

Gary E Schiltz

Kristen L Lauing

Lijie Zhai

Brandyn Castro

Rimas V Lukas

Miri Kim

Kathleen McCortney

Frequent Collaborators

Manon Penco-Campillo

Derek A Wainwright

Craig Horbinski

Gary E Schiltz